REV Group, Avidity Biosciences And Some Other Big Stocks Moving Higher On Wednesday

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

Avidity Biosciences, Inc. RNA shares jumped 44.3% to $15.84 after the company announced AOC 1001 data from the preliminary assessment of the Phase 1/2 MARINA trial demonstrating the first-ever successful targeted delivery of RNA into muscle.
Wave Life Sciences Ltd. WVE surged 21.1% to $5.80. SVB Leerink maintained WAVE Life Sciences with a Market Perform and raised the price target from $2 to $7.
Kymera Therapeutics, Inc. KYMR shares rose 21.4% to $31.38 after the company announced results from the Phase 1 clinical trial evaluating KT-474 in patients with HS and AD and Sanofi's decision to advance KT-474 into Phase 2 clinical trials.
REV Group, Inc. REVG rose 17.2% to $15.57 as the company reported a fourth-quarter FY22 sales growth of 5.7% year-over-year to $623.6 million, beating the consensus of $595 million.
Dyne Therapeutics, Inc. DYN gained 16.4% to $14.19.
Harmonic Inc. HLIT gained 12.9% to $14.86
Carvana Co. CVNA gained 12.8% to $5.45.
Harrow Health, Inc. HROW surged 11.9% to $12.43. Harrow Health entered a binding agreement to acquire the exclusive U.S. commercial rights to five FDA‑approved ophthalmic products from Novartis.
Bloom Energy Corporation BE gained 10.3% to $24.26. UBS initiated coverage on Bloom Energy with a Buy rating and announced a price target of $35.
Mullen Automotive, Inc. MULN jumped 10% to $0.2354. Mullen Automotive partnered with Loop Global to deploy EV charging solutions, including public DC fast charging network and residential offerings.
Oppenheimer Holdings Inc. OPY gained 9.7% to $44.19. Oppenheimer Holdings announced share repurchase program; authorizes the company to purchase up to 543,000 shares of the company's Class A non-voting common stock.
SoFi Technologies, Inc. SOFI rose 9.7% to $4.86. SoFi Technologies CEO Anthony Noto reported purchase of 1,134,065 shares at ab average price of $4.42 per share.
Mondee Holdings, Inc. MOND gained 8.8% to $9.50.
Plug Power Inc. PLUG rose 8.3% to $15.29. UBS initiated coverage on Plug Power with a Buy rating and announced a price target of $26.
Cytokinetics, Incorporated CYTK jumped 7.6% to $41.27. The FDA's Cardiovascular and Renal Drugs Advisory Committee voted 8-3 against the approval of Cytokinetics heart failure drug, omecamtiv mecarbil.